Immunology and Microbiology
Bispecific Antibody
98%
T Cell
95%
Cancer Cell
82%
Antineoplastic Activity
49%
Epithelial Cell Adhesion Molecule
42%
CD47
36%
Cancer Immunotherapy
32%
CD20
30%
TNF related apoptosis inducing ligand
26%
Myeloid
25%
Agonist
24%
Cytotoxicity
23%
Cell Surface
20%
Immunosuppressive Drug
19%
Carcinoma Cell
18%
Monospecific Antibody
17%
Adoptive Immunity
17%
Programmed Death-Ligand 1
16%
Tumor Cell
16%
Cell Death
15%
Rituximab
15%
Oleclumab
14%
CD7
14%
B Cell
14%
Cross Linking
13%
Tumor-Infiltrating Lymphocytes
13%
Antibody-Dependent Cell-Mediated Cytotoxicity
13%
Target Cell
13%
Inflammatory Arthritis
12%
Photochemical Internalization
12%
Therapeutic Antibodies
12%
T Helper 1 Cell
12%
Death Receptor
12%
Synovial Fluid
12%
Juvenile Idiopathic Arthritis
12%
Obinutuzumab
12%
Neutrophil
12%
Ecalectin
12%
Immune Checkpoint Blockade
12%
Tumor Necrosis Factor
12%
Gemtuzumab Ozogamicin
12%
Granulocyte
12%
Cross-Presentation
12%
T Cell Receptor
12%
C-Type Lectin
12%
Immunity
12%
Alemtuzumab
12%
Neck
12%
Cytotoxic T-Cell
12%
Daratumumab
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fusion Protein
100%
Neoplasm
84%
Epidermal Growth Factor Receptor
46%
Malignant Neoplasm
42%
Bispecific Antibody
33%
Epithelial Cell Adhesion Molecule
30%
Carcinoma
26%
Gemtuzumab Ozogamicin
24%
Elimination
23%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
22%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
21%
Cytotoxicity
18%
Leukemia
18%
Sodium Valproate
16%
T Cell Leukemia
15%
Acute Myeloid Leukemia
15%
Rituximab
15%
Fluorescein
15%
Histone Deacetylase Inhibitor
15%
Tracer
14%
Melanoma
14%
Fas Ligand
13%
Rheumatoid Arthritis
12%
Acute Lymphoblastic Leukemia
12%
Radioligand
12%
Programmed Cell Death
12%
6 Diazo 5 Oxonorleucine
12%
Alemtuzumab
12%
Mucin 1
12%
Death Receptor
12%
Colorectal Cancer
12%
Androstanolone
12%
Drug Delivery System
12%
Alginic Acid
12%
Colon Carcinoma
12%
Fluorine 18
12%
Enzalutamide
12%
Obinutuzumab
12%
Nuclear Magnetic Resonance Imaging Agent
12%
Gamma Urogastrone
12%
Brain Tumor
12%
Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand
12%
Ecalectin
12%
Head and Neck Cancer
12%
Temoporfin
12%
Tumor Necrosis Factor
12%
Azobenzene
12%
Bleomycin
12%
Daratumumab
12%
Androgen Receptor
12%
Medicine and Dentistry
Fusion Protein
57%
T Cell
52%
Programmed Cell Death
51%
Antineoplastic Activity
51%
Bispecific Antibody
33%
Epithelial Cell Adhesion Molecule
28%
Cell Surface
27%
Neoplasm
26%
Cancer Cell
25%
Carcinoma
25%
Target Cell
24%
Tumor Cell
23%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
19%
Cytotoxicity
17%
Carcinoma Cell
14%
Rituximab
14%
Nodular Melanoma
14%
Fas Ligand
13%
Antibody Dependent Cellular Cytotoxicity
13%
Cellular Immunity
13%
Adult T-Cell Leukemia/Lymphoma
13%
Cytomegalovirus
12%
Photochemical Internalization
12%
Death Receptor
12%
Positron Emission Tomography
12%
Fluorine-18
12%
Head and Neck Cancer
12%
Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand
12%
Immunosuppressive Drug
12%
Lectin
12%
Immune Checkpoint Blockade
12%
Adenosine
12%
Bleomycin
12%
Fluorescein
12%
Temoporfin
12%
Radioactive Tracer
12%
Granulocyte
12%
Chimeric Protein
12%
Malignant Neoplasm
9%
Acute Lymphoblastic Leukemia
9%
Leukemia
9%
Proteochondroitin Sulfate
8%
In Vitro
8%
Bortezomib
8%
Cancer Immunotherapy
7%
Blood Cell
7%
B Cell
6%
CD20
6%
Oleclumab
6%
Endothelial Cell
5%
